DK2310037T3 - Conglutin-gamma as-medikament og -kosttilskudpatentkrav - Google Patents

Conglutin-gamma as-medikament og -kosttilskudpatentkrav

Info

Publication number
DK2310037T3
DK2310037T3 DK09753933.2T DK09753933T DK2310037T3 DK 2310037 T3 DK2310037 T3 DK 2310037T3 DK 09753933 T DK09753933 T DK 09753933T DK 2310037 T3 DK2310037 T3 DK 2310037T3
Authority
DK
Denmark
Prior art keywords
conglutin
gamma
medicine
cost
patent requirements
Prior art date
Application number
DK09753933.2T
Other languages
English (en)
Inventor
Ileana Marina Terruzzi
Livio Luzi
Original Assignee
Policlinico San Donato S P A Istituto Di Ricovero E Cura A Carattere Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Policlinico San Donato S P A Istituto Di Ricovero E Cura A Carattere Scient filed Critical Policlinico San Donato S P A Istituto Di Ricovero E Cura A Carattere Scient
Application granted granted Critical
Publication of DK2310037T3 publication Critical patent/DK2310037T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Emergency Medicine (AREA)
DK09753933.2T 2008-05-30 2009-05-28 Conglutin-gamma as-medikament og -kosttilskudpatentkrav DK2310037T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5723508P 2008-05-30 2008-05-30
PCT/EP2009/056547 WO2009144278A2 (en) 2008-05-30 2009-05-28 USES OF CONGLUTIN-γ

Publications (1)

Publication Number Publication Date
DK2310037T3 true DK2310037T3 (da) 2014-10-27

Family

ID=41202838

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09753933.2T DK2310037T3 (da) 2008-05-30 2009-05-28 Conglutin-gamma as-medikament og -kosttilskudpatentkrav

Country Status (8)

Country Link
US (1) US8609161B2 (da)
EP (1) EP2310037B1 (da)
AU (1) AU2009253119A1 (da)
CA (1) CA2726231A1 (da)
DK (1) DK2310037T3 (da)
ES (1) ES2517640T3 (da)
HR (1) HRP20140998T1 (da)
WO (1) WO2009144278A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993008B1 (en) 2013-12-16 2015-03-31 Umm Al-Qura University Herbal composition for treating diabetes
US20200113969A1 (en) * 2016-09-30 2020-04-16 Instituto Superior De Agronomia Therapeutic protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5629199A (en) * 1999-09-16 2001-04-17 Valerie Tanvier Food flour enriched with animal proteins
DE20301675U1 (de) * 2003-02-04 2003-05-08 Ludwig, André, Dipl.-Kaufm., 46414 Rhede Getreidekugeln
ITMI20030237A1 (it) 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del
US20080032915A1 (en) 2004-02-12 2008-02-07 Campina Nederland Holding B.V. Cysteine Rich Peptides for Improving Thiol Homeostasis
ITMI20041308A1 (it) 2004-06-29 2004-09-29 Fraunhofer Ges Zur Foerderung... Processo per la purificazione da seme di lupiom di frazioni proteiche attive sul metabolismo lipidico

Also Published As

Publication number Publication date
AU2009253119A1 (en) 2009-12-03
US8609161B2 (en) 2013-12-17
WO2009144278A2 (en) 2009-12-03
EP2310037A2 (en) 2011-04-20
WO2009144278A3 (en) 2010-05-06
CA2726231A1 (en) 2009-12-03
US20110117226A1 (en) 2011-05-19
HRP20140998T1 (hr) 2014-12-19
ES2517640T3 (es) 2014-11-03
EP2310037B1 (en) 2014-07-23

Similar Documents

Publication Publication Date Title
FIC20250022I1 (fi) Atetsolitsumabi
NO2019015I1 (no) tezakaftor
NL300965I2 (nl) Patisiran
NL300961I2 (nl) Erenumab
NO2018009I2 (no) Dupilumab
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
NO2017048I1 (no) lotilaner
FIC20170031I1 (fi) alirokumabi
NO2017016I1 (no) iksazomib
DK2370462T3 (da) Glucagon-analoger
DK2342317T3 (da) Hængende-dråbe-plade
BRPI0907376A2 (pt) Fotobiorretador
NL301273I2 (nl) vamorolone
NO2016023I2 (no) Glycerolfenylbutyrat
DK2379557T3 (da) Aminopyrazol-forbindelse
FIU20080329U0 (fi) Kanylointisimulantti
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
EP2149500A4 (en) Electron beam sterilizer
EP2257170A4 (en) TETRAHYDROFUROPYRIDONE
EP2339366A4 (en) DEVICE FOR OPTICAL DISTANCE MEASUREMENT
DE112009001946A5 (de) Mobelauszugsführung
EP2285375A4 (en) SPIROAZAINDOLE
FI20080325A0 (fi) Pihkaliuos
FIU20080263U0 (fi) Suunhoitovalmiste
FR2926974B3 (fr) Perce-ongle